RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

RBC Capital analyst Arun Viswanathan maintained a Buy rating on Chemours Company (CC – Research Report) on January 16 and set a price target of ...

In a report released today, Christopher Snyder from Morgan Stanley maintained a Sell rating on 3M (MMM – Research Report), with a price target ...

Currently, no analysts following Palantir have set a target price above its recent close of $79.89, according to FactSet data ...

The bank, which has been under review by the Texas attorney general over its involvement in the Net-Zero Banking Alliance, ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $15.54 which represents a slight increase of $0.54 or 3.60% from the prior close of $15. The stock opened at $15.17 and touched ...

Morgan Stanley assigned a new analyst to cover hot artificial intelligence stock Palantir Technologies, and the Wall Street ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital ... the optimism that has prevailed in the markets since late 2022, the above average ...

Daniel Fannon; Analyst; Jefferies & Company Inc. Gerard Cassidy; Analyst; RBC Capital Markets ...

Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove ...